hexafluoroisopropanol has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, TE; Berger, JP; Bergeron, R; Castriota, GA; Chapman, KT; de Jesus, RK; Doebber, TW; Ellsworth, KP; Feng, Z; Lassman, ME; Levorse, DA; Li, C; Mills, SG; Owens, KA; Pasternak, A; Tang, H; Wu, MS; Yan, Y; Yang, L; Zhang, BB | 1 |
| Raleigh, DP; Tu, LH | 1 |
| Aebi, U; Cooper, GJ; Goldsbury, C; Green, JD; Kistler, J | 1 |
3 other study(ies) available for hexafluoroisopropanol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Carboxy-Lyases; Diabetes Mellitus, Type 2; Drug Design; Eating; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Obesity; Propanols; Thiazoles | 2010 |
Role of aromatic interactions in amyloid formation by islet amyloid polypeptide.
Topics: Amino Acid Sequence; Amino Acid Substitution; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Kinetics; Leucine; Models, Molecular; Molecular Sequence Data; Phenylalanine; Propanols; Tyrosine | 2013 |
Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation.
Topics: Adsorption; Amyloid; Amyloid beta-Peptides; Congo Red; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Microscopy, Atomic Force; Peptides; Propanols; Time Factors | 2004 |